• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金属蛋白酶-9/金属蛋白酶组织抑制剂-1系统对原发性高血压患者大动脉僵硬度的影响。

Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.

作者信息

Tan Jing, Hua Qi, Xing Xiurong, Wen Jing, Liu Rongkun, Yang Zheng

机构信息

Department of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing, PR China.

出版信息

Hypertens Res. 2007 Oct;30(10):959-63. doi: 10.1291/hypres.30.959.

DOI:10.1291/hypres.30.959
PMID:18049028
Abstract

The extracellular matrix is vital for maintaining tissue integrity, and the matrix metalloproteinases/tissue inhibitors of metalloproteinases (MMPs/TIMPs) system is involved in the regulation of extracellular matrix metabolism. Extracellular matrix turnover plays an important role in the change of large arterial mechanical properties in hypertension. However, the association of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 (MMP-9/TIMP-1) system and arterial stiffness is not straightforward and existing data are rather limited. Our objective is to explore the impact of the MMP-9/TIMP-1 system on large arterial stiffness in patients with essential hypertension. An automatic pulse wave velocity (PWV) measuring system was used to examine carotid-femoral PWV (CFPWV) and carotid-radial PWV (CRPWV) as the parameters reflecting central elastic large arterial and peripheral muscular medium-sized arterial elasticity, respectively; and serum MMP-9 and TIMP-1 levels, along with a number of other established biomarkers, were measured by enzyme-linked immunosorbent assay (ELISA) in 202 essential hypertensive patients and 54 age and gender-matched control subjects. Compared with the control subjects, hypertensive patients exhibited higher levels of MMP-9 (p=0.001) and TIMP-1 (p=0.002). Spearman's correlation analysis showed that serum levels of MMP-9 (p=0.014) and TIMP-1 (p=0.005) were significantly and positively correlated with CFPWV in hypertensive patients. A stepwise multiple regressive analysis demonstrated that age, systolic blood pressure, heart rate and TIMP-1 were independent predictors of CFPWV in patients with essential hypertension (adjusted r2=0.458). In conclusion, our results imply that the MMP-9/TIMP-1 system may play an important role in the determination of arterial function, and these findings may have implications for the involvement of MMP-9/TIMP-1 system in the pathophysiology of cardiovascular disease.

摘要

细胞外基质对于维持组织完整性至关重要,基质金属蛋白酶/金属蛋白酶组织抑制剂(MMPs/TIMPs)系统参与细胞外基质代谢的调节。细胞外基质周转在高血压患者大动脉力学特性变化中起重要作用。然而,金属蛋白酶-9/金属蛋白酶组织抑制剂-1(MMP-9/TIMP-1)系统与动脉僵硬度之间的关联并不直接,现有数据相当有限。我们的目的是探讨MMP-9/TIMP-1系统对原发性高血压患者大动脉僵硬度的影响。使用自动脉搏波速度(PWV)测量系统分别检测颈股PWV(CFPWV)和颈桡PWV(CRPWV),作为反映中心弹性大动脉和外周肌肉型中动脉弹性的参数;采用酶联免疫吸附测定(ELISA)法检测202例原发性高血压患者和54例年龄及性别匹配的对照者血清MMP-9和TIMP-1水平以及其他一些已确定的生物标志物。与对照者相比,高血压患者的MMP-9(p = 0.001)和TIMP-1(p = 0.002)水平较高。Spearman相关性分析显示,高血压患者血清MMP-9(p = 0.014)和TIMP-1(p = 0.005)水平与CFPWV显著正相关。逐步多元回归分析表明,年龄、收缩压、心率和TIMP-1是原发性高血压患者CFPWV的独立预测因素(调整后r2 = 0.458)。总之,我们的结果表明,MMP-9/TIMP-1系统可能在动脉功能的决定中起重要作用,这些发现可能对MMP-9/TIMP-1系统参与心血管疾病的病理生理学具有启示意义。

相似文献

1
Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.金属蛋白酶-9/金属蛋白酶组织抑制剂-1系统对原发性高血压患者大动脉僵硬度的影响。
Hypertens Res. 2007 Oct;30(10):959-63. doi: 10.1291/hypres.30.959.
2
Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness.基质金属蛋白酶-9(MMP-9)、MMP-2和血清弹性蛋白酶活性与收缩期高血压及动脉僵硬度相关。
Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):372. doi: 10.1161/01.ATV.0000151373.33830.41. Epub 2004 Nov 18.
3
[The changes and impact factors of carotid-femoral and carotid-radial pulse wave velocity in patients with essential hypertension].[原发性高血压患者颈股和颈桡脉搏波速度的变化及影响因素]
Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Dec;33(12):1088-91.
4
Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.妊娠期高血压患者循环中基质金属蛋白酶-9及金属蛋白酶组织抑制剂-1和-2的水平
Am J Hypertens. 2005 Mar;18(3):325-9. doi: 10.1016/j.amjhyper.2004.09.014.
5
Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.培哚普利对原发性高血压患者大动脉弹性和结构特性的影响。
Can J Cardiol. 2004 Jun;20(8):795-9.
6
Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.高血压患者体内的基质金属蛋白酶-2、-9及金属蛋白酶组织抑制剂-1
Endothelium. 2006 May-Jun;13(3):227-31. doi: 10.1080/10623320600780942.
7
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).基质金属蛋白酶-9和金属蛋白酶组织抑制因子-1在高血压中的作用及其与心血管风险和治疗的关系:盎格鲁-斯堪的纳维亚心脏结局试验(ASCOT)的一项子研究
Am J Hypertens. 2004 Sep;17(9):764-9. doi: 10.1016/j.amjhyper.2004.05.019.
8
Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects.I型胶原蛋白降解与高血压和血压正常受试者的动脉僵硬度有关。
J Hum Hypertens. 2006 Nov;20(11):867-73. doi: 10.1038/sj.jhh.1002015. Epub 2006 Apr 6.
9
Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.基质金属蛋白酶/金属蛋白酶组织抑制剂:基质成分蛋白水解决定因素的变化与高血压性心脏病的结构、功能及临床表现之间的关系
Circulation. 2006 May 2;113(17):2089-96. doi: 10.1161/CIRCULATIONAHA.105.573865. Epub 2006 Apr 24.
10
Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension.基质金属蛋白酶-9基因多态性与原发性高血压患者的血压及动脉僵硬度有关。
J Hum Hypertens. 2007 Nov;21(11):861-7. doi: 10.1038/sj.jhh.1002244. Epub 2007 Jun 21.

引用本文的文献

1
Analysis of Blood Components and Target Prediction for the Combined Use of Compound and Western Medicine in Antihypertensive Therapy Based on Network Pharmacology and Molecular Docking.基于网络药理学和分子对接的中西医结合治疗高血压的血液成分分析及靶点预测
Drug Des Devel Ther. 2025 Aug 12;19:6965-6989. doi: 10.2147/DDDT.S522471. eCollection 2025.
2
Ferulic Acid Attenuates Aortic Stiffening and Cardiovascular Remodeling by Suppressing Inflammation and the Renin-Angiotensin System in Rats Fed a High-Fat/High-Carbohydrate Diet.阿魏酸通过抑制高脂/高碳水化合物饮食喂养大鼠的炎症反应和肾素-血管紧张素系统来减轻主动脉硬化和心血管重塑。
J Obes Metab Syndr. 2025 Jul 30;34(3):291-302. doi: 10.7570/jomes24017. Epub 2025 Jun 9.
3
Canagliflozin improves high-salt-induced aortic arteriosclerosis and premature aging in dahl salt-sensitive rats through the SIRT6/HIF-1 α signaling pathway.
卡格列净通过SIRT6/HIF-1α信号通路改善高盐诱导的 Dahl 盐敏感大鼠的主动脉动脉硬化和早衰。
Mol Cell Biochem. 2025 Jun 2. doi: 10.1007/s11010-025-05321-z.
4
Current Prognostic Biomarkers for Peripheral Arterial Disease: A Comprehensive Systematic Review of the Literature.外周动脉疾病的当前预后生物标志物:文献的全面系统综述
Metabolites. 2025 Mar 25;15(4):224. doi: 10.3390/metabo15040224.
5
Convergence of endothelial dysfunction, inflammation and glucocorticoid resistance in depression-related cardiovascular diseases.在与抑郁相关的心血管疾病中,内皮功能障碍、炎症和糖皮质激素抵抗的汇聚。
BMC Immunol. 2024 Sep 27;25(1):61. doi: 10.1186/s12865-024-00653-9.
6
Association between six different types of anthropometric indices and arterial stiffness measured by brachial-ankle pulse wave velocity in hypertensive Chinese adults.中国高血压成年人中六种不同类型人体测量指数与通过臂踝脉搏波速度测量的动脉僵硬度之间的关联。
Heliyon. 2024 Mar 27;10(7):e28523. doi: 10.1016/j.heliyon.2024.e28523. eCollection 2024 Apr 15.
7
Plasma and cerebrospinal fluid proteomic signatures of acutely sleep-deprived humans: an exploratory study.急性睡眠剥夺人群的血浆和脑脊液蛋白质组学特征:一项探索性研究。
Sleep Adv. 2023 Nov 14;4(1):zpad047. doi: 10.1093/sleepadvances/zpad047. eCollection 2023.
8
Matrix Metalloproteinases and Heart Transplantation-A Pathophysiological and Clinical View.基质金属蛋白酶与心脏移植:病理生理学与临床观察
Medicina (Kaunas). 2023 Jul 13;59(7):1295. doi: 10.3390/medicina59071295.
9
Involvement of Matrix Metalloproteinases in COVID-19: Molecular Targets, Mechanisms, and Insights for Therapeutic Interventions.基质金属蛋白酶在新型冠状病毒肺炎中的作用:分子靶点、机制及治疗干预见解
Biology (Basel). 2023 Jun 10;12(6):843. doi: 10.3390/biology12060843.
10
A functional -1562C>T polymorphism, MMP-9 serum levels and nephrolithiasis risk in a southern Chinese population.中国南方人群中功能性-1562C>T多态性、基质金属蛋白酶-9血清水平与肾结石风险
Front Med (Lausanne). 2023 Jun 2;10:1175798. doi: 10.3389/fmed.2023.1175798. eCollection 2023.